Acinetobacter baumannii Infection in Prior ICU Bed Occupants Is an Independent Risk Factor for Subsequent Cases of Ventilator-Associated Pneumonia

Table 5

Clinical outcome measures in patients with VAP due to Acinetobacter baumannii.

	Non-VAP; 𝑛=147	AbVAP; 𝑛=22	VAP due to other pathogens; 𝑛=24
Other infections	38 (26%)*	13 (59%)	17 (71%)
Urinary tract infection	12 (8%)*	7 (32%)	6 (25%)
Intravenous catheter infection	15 (10%)*	6 (27%)	9 (38%)
Bacteremia in ICU	28 (19%)*	13 (59%)	14 (58%)
Other infections due to MDR	10 (7%)*	9 (41%)	7 (29%)
Sepsis	30 (20%)*	16 (73%)	19 (79%)
ICU stay (days)	12 ± 9*	25 ± 17	34 ± 23
ICU mortality	87 (59%)	15 (68%)	15 (62%)

Data are presented as 𝑛 (%) or mean (±SD).
VAP: ventilator-associated pneumonia, ICU: intensive care unit, and MDR: multidrug-resistant bacteria.
Other infections included bacteremia, urinary tract infection, and infection of intravenous catheter.
^∗𝑃 value between AbVAP and non-VAP patients.